Scientists in Asia and Africa are racing to discover hardier crop varieties using gene editing tools. But patent restrictions ...

Cathie Wood of ARK Investment is one of Wall Street’s most well-known hedge fund bosses. In a hedge fund industry dominated ...

A research team have recently published their article, "Rationally designed pooled CRISPRi-seq uncovers an inhibitor of ...

Thanks to CRISPR, medical specialists will soon have unprecedented control over how they treat and prevent some of the most ...

How does CRISPR work, and why is editing human embryos so controversial? Explore the science, the risks, and the ethical debates surrounding Dr. He Jiankui’s gene-editing experiment.

CRISPR Therapeutics' Q3 saw reduced expenses and slow Casgevy launch, resulting in a revenue miss. Read why I am neutral on ...

Researchers in Lithuania present the molecular structure of a new, more-versatile CRISPR system for gene editing.

Thanks to the revolutionary advancements in CRISPR technology, medical specialists are on the verge of transforming how we ...

CRISPR Therapeutics (CRSP) presented data from the Company’s ongoing Phase 1/2 dose escalation clinical trial evaluating the safety and ...

Researchers have uncovered a serious side effect of using the CRISPR-Cas gene scissors. A molecule designed to make the process more efficient destroys parts of the genome.

Evercore ISI analyst Liisa Bayko maintained a Hold rating on Crispr Therapeutics AG (CRSP – Research Report) today and set a price target of ...